US3929791A
Expired / Lapsed
US
⏱️ 0.0 years remaining
2 Substituted-10{8 4-(2-oxazolidi none-lower alkyl){9 -piperazine-dibenzo{8 b,f{9 thiepins
Assignee: F Hoffmann La Roche AG
•
Filing: 1973-07-12
•
Granted: 1975-12-30
•
Expires: 1993-07-12
Abstract
Abstract Dibenzothiepin derivatives of the general formula WHEREIN M, N, R1, R2, R3 and X are as hereinafter set forth, AND SALTS THEREOF AS WELL AS PROCESSES FOR THEIR MANUFACTURE ARE DISCLOSED. The end products are useful as central-depressant and neuroleptic agents.
Inventors
- 👤 Max Gerecke
- 👤 Jean-Pierre Kaplan
- 👤 Emilio Kyburz
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 09:32
CPC Classifications
C; C07; C07D; C07D337/00; C07D337/02; C07D337/06; C07D337/10; C07D337/14; C07C; C07C323/00; C07C51/00; C07C51/347; C07C51/363
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
5 words
A COMPOUND OF THE FORMULA
Claim 2
Dependent Claim
5 words
A COMPOUND OF THE FORMULA
Claim 3
Dependent Claim
10 words
A compound in accordance with claim 1 having the formula
Claim 4
Dependent Claim
17 words
A compound in accordance with claim 2, wherein n is 2, R1 is halogen, trifluoromethyl or methyl.
Claim 5
Dependent Claim
17 words
A compound in accordance with claim 3, 3-(2-(4-(2-chloro-10, 11-dihydro-dibenzo(b,f)thiepin-10-yl)-1-piperazinyl)-ethyl)-2-oxazolidinone or a pharmaceutically acceptable acid addition salt thereof.
Claim 6
Dependent Claim
17 words
A compound in accordance with claim 3, 3-(2-(4-(10,11-dihydro-2methyl-dibenzo(b,f)thiepin-10-yl)-1-piperazinyl) -ethyl)-2-oxazolidinone or a pharmaceutically acceptable acid addition salt thereof.
Claim 7
Dependent Claim
10 words
A compound in accordance with claim 1 having the formula
Claim 8
Dependent Claim
14 words
A compound in accordance with claim 6, wherein n is 2, R1 is halogen.
Claim 9
Dependent Claim
10 words
3-(2-(4-(2-Chloro-dibenzo(b,f)thiepin-10-yl)-1-piperazinyl)-ethyl)2 -oxazolidinone or a pharmaceutically acceptable acid addition salt thereof.
Claim 10
Dependent Claim
10 words
3-(2-(4-(2-Chloro-dibenzo(b,f)thiepin-10-yl)-1-piperazinyl)-ethyl)2 -oxazolidinone or a pharmaceutically acceptable acid addition salt thereof.
Claim 11
Dependent Claim
10 words
3-(2-(4-(10,11-dihydro-2-dimethylamino-dibenzo(b,f)thiepin-10-yl)1 -piperazinyl)-ethyl)-2-oxazolidinone or a pharmaceutically acceptable acid addition salt thereof.
Claim 12
Dependent Claim
10 words
3-(2-(4-(10,11-dihydro-2-dimethylamino-dibenzo(b,f)thiepin-10-yl)1 -piperazinyl)-ethyl)-2-oxazolidinone or a pharmaceutically acceptable acid addition salt thereof.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1978-12-29 | 1979-06-30 | 1979-12-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1982-12-29 | 1983-06-30 | 1983-12-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1986-12-29 | 1987-06-30 | 1987-12-30 | $7700.00 | Window Closed / Lapsed |